The Efficacy, Safety and Immunogenicity Study of Inactivated SARS-CoV-2 Vaccine for Preventing Against COVID-19

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
This is a randomized, double-blinded, placebo controlled phase III clinical trial to evaluate the efficacy, safety and immunogenicity of SARS-CoV-2 Vaccine, Inactivated (Vero Cell) in adults aged 18 years and above after 2-dose schedule.
Epistemonikos ID: 99cee5f793a93dd75cef88e5ab9285a5bfd06a7d
First added on: Dec 10, 2020